Automatic  ||| S:0 E:10 ||| NNP
Classification  ||| S:10 E:25 ||| NNP
and  ||| S:25 E:29 ||| CC
Quantification  ||| S:29 E:44 ||| NNP
of  ||| S:44 E:47 ||| IN
Cell  ||| S:47 E:52 ||| NNP
Adhesion  ||| S:52 E:61 ||| NNP
Locations  ||| S:61 E:71 ||| NNP
on  ||| S:71 E:74 ||| IN
the  ||| S:74 E:78 ||| DT
Endothelium  ||| S:78 E:90 ||| NNP
To  ||| S:90 E:93 ||| TO
target  ||| S:93 E:100 ||| VB
tumor  ||| S:100 E:106 ||| NN
hematogenous  ||| S:106 E:119 ||| NN
metastasis  ||| S:119 E:130 ||| NNS
and  ||| S:130 E:134 ||| CC
to  ||| S:134 E:137 ||| TO
understand  ||| S:137 E:148 ||| VB
how  ||| S:148 E:152 ||| WRB
leukocytes  ||| S:152 E:163 ||| NNS
cross  ||| S:163 E:169 ||| VBP
the  ||| S:169 E:173 ||| DT
microvessel  ||| S:173 E:185 ||| JJ
wall  ||| S:185 E:190 ||| NN
to  ||| S:190 E:193 ||| TO
perform  ||| S:193 E:201 ||| VB
immune  ||| S:201 E:208 ||| JJ
functions ||| S:208 E:217 ||| NNS
,  ||| S:217 E:219 ||| ,
it  ||| S:219 E:222 ||| PRP
is  ||| S:222 E:225 ||| VBZ
necessary  ||| S:225 E:235 ||| JJ
to  ||| S:235 E:238 ||| TO
elucidate  ||| S:238 E:248 ||| VB
the  ||| S:248 E:252 ||| DT
adhesion  ||| S:252 E:261 ||| JJ
location  ||| S:261 E:270 ||| NN
and  ||| S:270 E:274 ||| CC
transmigration  ||| S:274 E:289 ||| JJ
pathway  ||| S:289 E:297 ||| NN
of  ||| S:297 E:300 ||| IN
tumor  ||| S:300 E:306 ||| NN
cells  ||| S:306 E:312 ||| NNS
and  ||| S:312 E:316 ||| CC
leukocytes  ||| S:316 E:327 ||| NN
on ||| S:327 E:329 ||| IN
/ ||| S:329 E:330 ||| CD
across  ||| S:330 E:337 ||| IN
the  ||| S:337 E:341 ||| DT
endothelial  ||| S:341 E:353 ||| JJ
cells  ||| S:353 E:359 ||| NNS
forming  ||| S:359 E:367 ||| VBG
the  ||| S:367 E:371 ||| DT
microvessel  ||| S:371 E:383 ||| JJ
wall ||| S:383 E:387 ||| NN
.  ||| S:387 E:389 ||| .
We  ||| S:389 E:392 ||| PRP
developed  ||| S:392 E:402 ||| VBD
an  ||| S:402 E:405 ||| DT
algorithm  ||| S:405 E:415 ||| NN
to  ||| S:415 E:418 ||| TO
classify  ||| S:418 E:427 ||| VB
and  ||| S:427 E:431 ||| CC
quantify  ||| S:431 E:440 ||| JJ
cell  ||| S:440 E:445 ||| NN
adhesion  ||| S:445 E:454 ||| NN
locations  ||| S:454 E:464 ||| NNS
from  ||| S:464 E:469 ||| IN
photomicrographs  ||| S:469 E:486 ||| VBG
taken  ||| S:486 E:492 ||| VBN
from  ||| S:492 E:497 ||| IN
the  ||| S:497 E:501 ||| DT
experiments  ||| S:501 E:513 ||| NNS
of  ||| S:513 E:516 ||| IN
tumor  ||| S:516 E:522 ||| NN
cell ||| S:522 E:526 ||| NN
/ ||| S:526 E:527 ||| CD
leukocyte  ||| S:527 E:537 ||| JJ
adhesion  ||| S:537 E:546 ||| NN
in  ||| S:546 E:549 ||| IN
individual  ||| S:549 E:560 ||| JJ
microvessels ||| S:560 E:572 ||| NN
.  ||| S:572 E:574 ||| .
The  ||| S:574 E:578 ||| DT
first  ||| S:578 E:584 ||| JJ
step  ||| S:584 E:589 ||| NN
is  ||| S:589 E:592 ||| VBZ
to  ||| S:592 E:595 ||| TO
identify  ||| S:595 E:604 ||| VB
the  ||| S:604 E:608 ||| DT
microvessel  ||| S:608 E:620 ||| NN
by  ||| S:620 E:623 ||| IN
a  ||| S:623 E:625 ||| DT
novel  ||| S:625 E:631 ||| NN
gravity-field  ||| S:631 E:645 ||| JJ
dynamic  ||| S:645 E:653 ||| JJ
programming  ||| S:653 E:665 ||| NN
( ||| S:665 E:666 ||| -LRB-
DP ||| S:666 E:668 ||| NNP
)  ||| S:668 E:670 ||| -RRB-
procedure ||| S:670 E:679 ||| NN
.  ||| S:679 E:681 ||| .
Next ||| S:681 E:685 ||| JJ
,  ||| S:685 E:687 ||| ,
an  ||| S:687 E:690 ||| DT
anisotropic  ||| S:690 E:702 ||| JJ
image  ||| S:702 E:708 ||| NN
smoothing  ||| S:708 E:718 ||| NNS
suppresses  ||| S:718 E:729 ||| VBP
noises  ||| S:729 E:736 ||| VBN
without  ||| S:736 E:744 ||| IN
unduly  ||| S:744 E:751 ||| RB
mitigating  ||| S:751 E:762 ||| VBG
crucial  ||| S:762 E:770 ||| JJ
visual  ||| S:770 E:777 ||| JJ
features ||| S:777 E:785 ||| NNS
.  ||| S:785 E:787 ||| .
After  ||| S:787 E:793 ||| IN
an  ||| S:793 E:796 ||| DT
adaptive  ||| S:796 E:805 ||| JJ
thresholding  ||| S:805 E:818 ||| JJ
process  ||| S:818 E:826 ||| NN
further  ||| S:826 E:834 ||| RBR
tackles  ||| S:834 E:842 ||| JJ
uneven  ||| S:842 E:849 ||| JJ
lighting  ||| S:849 E:858 ||| NN
conditions  ||| S:858 E:869 ||| NNS
during  ||| S:869 E:876 ||| IN
the  ||| S:876 E:880 ||| DT
imaging  ||| S:880 E:888 ||| JJ
process ||| S:888 E:895 ||| NN
,  ||| S:895 E:897 ||| ,
a  ||| S:897 E:899 ||| DT
series  ||| S:899 E:906 ||| NN
of  ||| S:906 E:909 ||| IN
local  ||| S:909 E:915 ||| JJ
mathematical  ||| S:915 E:928 ||| JJ
morphological  ||| S:928 E:942 ||| JJ
operators  ||| S:942 E:952 ||| NNS
and  ||| S:952 E:956 ||| CC
eigenanalysis  ||| S:956 E:970 ||| RB
identify  ||| S:970 E:979 ||| VB
tumor  ||| S:979 E:985 ||| NN
cells  ||| S:985 E:991 ||| NNS
or  ||| S:991 E:994 ||| CC
leukocytes ||| S:994 E:1004 ||| NN
.  ||| S:1004 E:1006 ||| .
Finally ||| S:1006 E:1013 ||| RB
,  ||| S:1013 E:1015 ||| ,
a  ||| S:1015 E:1017 ||| DT
novel  ||| S:1017 E:1023 ||| NN
double  ||| S:1023 E:1030 ||| JJ
component  ||| S:1030 E:1040 ||| NN
labeling  ||| S:1040 E:1049 ||| NN
procedure  ||| S:1049 E:1059 ||| NN
categorizes  ||| S:1059 E:1071 ||| VBD
the  ||| S:1071 E:1075 ||| DT
cell  ||| S:1075 E:1080 ||| NN
adhesion  ||| S:1080 E:1089 ||| NN
locations ||| S:1089 E:1098 ||| NNS
.  ||| S:1098 E:1100 ||| .
This  ||| S:1100 E:1105 ||| DT
algorithm  ||| S:1105 E:1115 ||| NN
has  ||| S:1115 E:1119 ||| VBZ
generated  ||| S:1119 E:1129 ||| VBN
consistently  ||| S:1129 E:1142 ||| RB
encouraging  ||| S:1142 E:1154 ||| JJ
performances  ||| S:1154 E:1167 ||| NNS
on  ||| S:1167 E:1170 ||| IN
photomicrographs  ||| S:1170 E:1187 ||| VBG
obtained  ||| S:1187 E:1196 ||| VBN
from  ||| S:1196 E:1201 ||| IN
in  ||| S:1201 E:1204 ||| IN
vivo  ||| S:1204 E:1209 ||| JJ
experiments  ||| S:1209 E:1221 ||| NNS
for  ||| S:1221 E:1225 ||| IN
tumor  ||| S:1225 E:1231 ||| NN
cell  ||| S:1231 E:1236 ||| NN
and  ||| S:1236 E:1240 ||| CC
leukocyte  ||| S:1240 E:1250 ||| JJ
adhesion  ||| S:1250 E:1259 ||| JJ
locations  ||| S:1259 E:1269 ||| NNS
on  ||| S:1269 E:1272 ||| IN
the  ||| S:1272 E:1276 ||| DT
endothelium  ||| S:1276 E:1288 ||| NN
forming  ||| S:1288 E:1296 ||| VBG
the  ||| S:1296 E:1300 ||| DT
microvessel  ||| S:1300 E:1312 ||| JJ
wall ||| S:1312 E:1316 ||| NN
.  ||| S:1316 E:1318 ||| .
Compared  ||| S:1318 E:1327 ||| VBN
with  ||| S:1327 E:1332 ||| IN
human  ||| S:1332 E:1338 ||| JJ
experts ||| S:1338 E:1345 ||| NNS
,  ||| S:1345 E:1347 ||| ,
this  ||| S:1347 E:1352 ||| DT
algorithm  ||| S:1352 E:1362 ||| NN
used  ||| S:1362 E:1367 ||| VBD
1 ||| S:1367 E:1368 ||| CD
/ ||| S:1368 E:1369 ||| CD
500-1 ||| S:1369 E:1374 ||| CD
/ ||| S:1374 E:1375 ||| CD
200  ||| S:1375 E:1379 ||| CD
of  ||| S:1379 E:1382 ||| IN
the  ||| S:1382 E:1386 ||| DT
time  ||| S:1386 E:1391 ||| NN
without  ||| S:1391 E:1399 ||| IN
having  ||| S:1399 E:1406 ||| VBG
the  ||| S:1406 E:1410 ||| DT
errors  ||| S:1410 E:1417 ||| NNS
due  ||| S:1417 E:1421 ||| JJ
to  ||| S:1421 E:1424 ||| TO
human  ||| S:1424 E:1430 ||| JJ
subjectivity ||| S:1430 E:1442 ||| NN
.  ||| S:1442 E:1444 ||| .
Our  ||| S:1444 E:1448 ||| PRP$
automatic  ||| S:1448 E:1458 ||| JJ
classification  ||| S:1458 E:1473 ||| NN
and  ||| S:1473 E:1477 ||| CC
quantification  ||| S:1477 E:1492 ||| JJ
method  ||| S:1492 E:1499 ||| NN
provides  ||| S:1499 E:1508 ||| VBZ
a  ||| S:1508 E:1510 ||| DT
reliable  ||| S:1510 E:1519 ||| JJ
and  ||| S:1519 E:1523 ||| CC
cost  ||| S:1523 E:1528 ||| VB
effective  ||| S:1528 E:1538 ||| JJ
approach  ||| S:1538 E:1547 ||| NN
for  ||| S:1547 E:1551 ||| IN
biomedical  ||| S:1551 E:1562 ||| JJ
image  ||| S:1562 E:1568 ||| NN
processing ||| S:1568 E:1578 ||| NN
.  ||| S:1578 E:1580 ||| .
